-
HDAC3 mediates the inflammatory response and LPS tolerance in human monocytes and macrophages
Study
EGAS00001004218
-
The impact of urbanization and diet on innate immune responses in healthy Tanzanians
Study
EGAS00001004284
-
Searching for genetic modulators of the phenotypic heterogeneity in Brugada Syndrome
Study
EGAS00001005848
-
GCAT| WGS Structural Variants Catalog V1
Dataset
EGAD00010002152
-
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Dataset
EGAD00001001359
-
analysis of T cell receptor repertoirs
Dataset
EGAD00001008109
-
H3Africa EPIGEN Phenotype
Dataset
EGAD00001009739
-
atrial appendage miRNA-seq in non-, paroxysmal and persistent atrial fibrillation
Dataset
EGAD00001007694
-
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways
Dataset
EGAD00001011067
-
Tanzania dietary intervention study 2019-2020
Dataset
EGAD50000000457
-
Gain of Function Mutations in RPA1
Dataset
EGAD00001008329
-
GIS-LUNGTCR1-2016_VAL-BAM
Dataset
EGAD00001001980
-
LabExMI_SNP_genotyping
Dataset
EGAD00010001489
-
Mosaic Colorectal Metastasis
Dataset
EGAD00001000948
-
Epigenetic Intratumor Heterogeneity and Clonal Evolution in Aggressive Prostate Cancer
Study
EGAS00001000682
-
Genetics of male infertility in India
Study
EGAS00001008171
-
Epigenome-wide association study of cocaine use disorder in postmortem human brain tissue
Dataset
EGAD00010002396
-
Whole-Exome Sequencing Plasma Control Samples for Benchmarking
Study
EGAS50000000565
-
Cohort B tumor exome sequencing
Study
EGAS50000000955
-
Coloured individuals from South Africa
Study
EGAS50000000352
-
Immunoglobulin Heavy-Chain locus in Multiple Sclerosis (n=4)
Dataset
EGAD50000001517
-
DNA sequencing of sgRNAs in CRISPR-Cas9 screening and RNA sequencing of SF3B4-overexpressing liver organoids
Dataset
EGAD50000001625
-
RNA fastq files and mutation annotation files
Dataset
EGAD50000001768
-
IGPP Consortium GWSS Summary Results Data
Dataset
EGAD00001007060
-
CM214 - Biomarker Analysis From the Phase 3 CheckMate 214 Trial of Nivolumab Plus Ipilimumab (N+I) or Sunitinib (S) in Advanced Renal Cell Carcinoma (aRCC)
Dataset
EGAD00001007938